PD Dr. Dennis Lapuente

Institute of Clinical and Molecular Virology

Evaluation of adenoviral vector Ad19a encoding RSV-F as novel vaccine against respiratory syncytial virus (2024) Fuchs J, Hübner J, Schmidt A, Irrgang P, Maier C, Vieira Antao AI, Oltmanns F, et al. Journal article Filling two needs with one deed: a combinatory mucosal vaccine against influenza A virus and respiratory syncytial virus (2024) Vieira Antao AI, Oltmanns F, Schmidt A, Viherlehto V, Irrgang P, Rameix-Welti MA, Bayer W, et al. Journal article Mucosal tumor vaccination delivering endogenous tumor antigens protects against pulmonary breast cancer metastases (2024) Oltmanns F, Vieira Antao AI, Irrgang P, Viherlehto V, Jörg L, Schmidt A, Wagner J, et al. Journal article Alcohol-sourced acetate impairs T cell function by promoting cortactin acetylation (2023) Azizov V, Hübner M, Frech M, Hofmann J, Kubankova M, Lapuente D, Tenbusch M, et al. Journal article B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity (2023) Lapuente D, Winkler TH, Tenbusch M Journal article, Review article Class switch towards non-inflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination (2022) Irrgang P, Gerling J, Kocher K, Lapuente D, Steininger P, Habenicht KM, Wytopil M, et al. Journal article Immune suppression of vaccine-induced CD8(+) T-cell responses by gamma retrovirus envelope is mediated by interleukin-10-producing CD4(+) T cells (2022) Podschwadt P, Malyshkina A, Windmann S, Papadamakis A, Kerkmann L, Lapuente D, Tenbusch M, et al. Journal article Differential induction of lung-resident memory T cells through infection or viral vector immunization (2022) Schmidt A, Fuchs J, Lapuente D, Huebner J, Vieira Antao AI, Irrgang P, Paudyal B, et al. Conference contribution Protective mucosal immunity against SARS-CoV-2 after heterologous systemic RNA-mucosal adenoviral vector immunization (2022) Lapuente D, Fuchs J, Willar J, Antao A, Eberlein V, Uhlig N, Issmail L, et al. Conference contribution Mucosal vaccination with a viral vector vaccine induces robust lung-resident T cell responses and protects against 4T1 metastasis (2022) Oltmanns F, Vieira Antao AI, Irrgang P, Meyn V, Jörg L, Tenbusch M, Lapuente D Conference contribution